Morgan, M. R. “Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism”. Science and Technology Law Review, vol. 11, Nov. 2009, doi:10.7916/stlr.v11i0.3846.